| Ident. | Authors (with country if any) | Title |
|---|
| 000010 (2020) |
Corneliu P. Popescu [Roumanie] ; Philip R. Fischer [États-Unis] | Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous? |
| 000011 (2020) |
Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France] | Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. |
| 000015 (2020) |
Patricia Schlagenhauf [Suisse] ; Martin P. Grobusch [Pays-Bas] ; Julian D. Maier [Suisse] ; Philippe Gautret [France] | Repurposing antimalarials and other drugs for COVID-19. |
| 000016 (2020) |
Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France] | Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study. |
| 000047 (2020) |
Lucie Pothen [Belgique] ; Halil Yildiz [Belgique] ; Julien De Greef [Belgique] ; Andrea Penaloza [Belgique] ; Christophe Beauloye [Belgique] ; Leila Belkhir [Belgique] ; Jean Cyr Yombi [Belgique] | Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center. |
| 000051 (2020) |
Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France] | Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. |
| 000053 (2020) |
David Lebeaux [France] ; Matthieu Revest [France] | No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". |
| 000060 (2020) |
M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France] | Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence. |
| 000061 (2020) |
Isabelle Lacroix [France] ; Justine Bénévent [France] ; Christine Damase-Michel [France] | Chloroquine and hydroxychloroquine during pregnancy: What do we know? |
| 000063 (2020) |
Lucile Grange [France] ; Philippe Guilpain [France] ; Marie-Elise Truchetet [France] ; Jean-Luc Cracowski [France] | Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review. |
| 000065 (2020) |
Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France] | "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. |
| 000117 (2020) |
L. Boyer [France] ; P. Auquier [France] ; G. Fond [France] | [Real-life data and Covid-19: The third avenue of reseach]. |
| 000149 (2020) |
S. Defoort-Dhellemmes [France] | [Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?] |
| 000467 (2020) |
François Danion [France] ; Yvon Ruch [France] ; Marion Fourtage [France] ; Charlotte Kaeuffer [France] ; Valentin Greigert [France] ; Nicolas Lefebvre [France] ; Joris Muller [France] ; Thierry Nai [France] ; Yves Hansmann [France] | The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19. |
| 000493 (2020) |
Justin T. Denholm [Australie] ; Joshua Davis [Australie] ; David Paterson [Australie] ; Jason Roberts [Australie, France] ; Susan Morpeth [Nouvelle-Zélande] ; Thomas Snelling [Australie] ; Dominica Zentner [Australie] ; Megan Rees [Australie] ; Matthew O'Sullivan [Australie] ; David Price [Australie] ; Asha Bowen [Australie] ; Steven Y C. Tong [Australie] | The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. |
| 000513 (2020) |
Achille Aouba [Oman] ; Aurelie Baldolli [France] ; Loïk Geffray [France] ; Renaud Verdon [France] ; Emmanuel Bergot [France] ; Nicolas Martin-Silva [France] ; Aurélien Justet [France] | Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series. |
| 000535 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000536 (2020) |
Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal. |
| 000541 (2020) |
Sebastian E. Sattui [États-Unis] ; Jean W. Liew [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Ariella Coler-Reilly [États-Unis] ; Francis Berenbaum [France] ; Alí Duarte-García [États-Unis] ; Carly Harrison [États-Unis] ; Maximilian F. Konig [États-Unis] ; Peter Korsten [Allemagne] ; Michael S. Putman [États-Unis] ; Philip C. Robinson [Australie] ; Emily Sirotich [Canada] ; Manuel F. Ugarte-Gil [Pérou] ; Kate Webb [Afrique du Sud, Royaume-Uni] ; Kristen J. Young [États-Unis] ; Alfred H J. Kim [États-Unis] ; Jeffrey A. Sparks [États-Unis] | Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. |
| 000563 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000745 (2020) |
Christian Funck-Brentano [France] ; Joe-Elie Salem [France] ; Lee S. Nguyen [France] ; Milou-Daniel Drici [France] ; Dan M. Roden [États-Unis] | Response to the editorial "COVID-19 in patients with cardiovascular diseases": Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes. |
